ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users

ClinicalTrials.gov ID: NCT04995029

Public ClinicalTrials.gov record NCT04995029. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 12:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomised, Double-Blind Study Comparing 2 Maintenance Dosing Regimens of Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in Treatment-Seeking Adult Participants With Opioid Use Disorder and High-risk Opioid Use

Study identification

NCT ID
NCT04995029
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Indivior Inc.
Industry
Enrollment
785 participants

Conditions and interventions

Interventions

  • Extended-release Buprenorphine Drug
  • Transmucosal Buprenorphine Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 25, 2021
Primary completion
Jun 25, 2024
Completion
Jun 25, 2024
Last update posted
Feb 5, 2026

2021 – 2024

United States locations

U.S. sites
28
U.S. states
12
U.S. cities
24
Facility City State ZIP Site status
Collaborative Neuroscience Network, LLC Garden Grove California 92845
Asclepes Research Centers Panorama City California 91402
Artemis Institute for Clinical Research San Diego California 92103
Bay Pines VA Healthcare System Bay Pines Florida 33744
Sarkis Clinical Trials Gainesville Florida 32607
Accel Research Sites- Lakeland Clinical Research Unit Lakeland Florida 33803
Behavioral Clinical Research, Inc Miami Lakes Florida 33016
Innovative Clinical Research Inc. North Miami Florida 33161
Clinical Neuroscience Solutions, Inc Orlando Florida 32801
Brigham and Women's Hospital Boston Massachusetts 02115
Hassman Research Institute Berlin New Jersey 08009
Center For Emotional Fitness Cherry Hill New Jersey 08002
ICAHN School of Medicine at Mount Sinai New York New York 10029
Duke Hospital Durham North Carolina 27705
Monroe Biomedical Research Monroe North Carolina 28112
Midwest Clinical Research Dayton Ohio 45417
Pahl Pharmaceutical Professionals LLC Oklahoma City Oklahoma 73112
SP Research, PLLC Oklahoma City Oklahoma 73112
Unity Clinical Research Oklahoma City Oklahoma 73118
Today Clinical Research Oklahoma City Oklahoma 73120
Clinical Research Associates of Central PA Altoona Pennsylvania 16602
Carolina Medical Research, LLC Clinton South Carolina 29325
Prisma Health ITOR Research Pharmacy Greenville South Carolina 29605
Carolina Medical Research, LLC Greenville South Carolina 29607
David Weitzman Myrtle Beach South Carolina 29577
Insite Clinical Research DeSoto Texas 75115
Progressive Clinical Research Bountiful Utah 84010
Alpine Research Organization Clinton Utah 84015

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04995029, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 5, 2026 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04995029 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →